The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

Background There is uncertainty in deferred active treatment (DAT) programmes, regarding
patient selection, follow-up and monitoring, reclassification, and which outcome measures …

In the last decade, active surveillance (AS) has emerged as an acceptable choice for low-
risk prostate cancer (PC), however there is discordance amongst large AS cohort studies …

In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to
increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) …

Objectives The PRECISE recommendations for magnetic resonance imaging (MRI) in
patients on active surveillance (AS) for prostate cancer (PCa) include repeated …

Background Careful assessment of the reasons for discontinuation of active surveillance
(AS) is required for men with prostate cancer (PCa). Objective Using Movember's Global …

Background Conservative management is an option for prostate cancer (PCa) patients
either with the objective of delaying or even avoiding curative therapy, or to wait until …

Many men diagnosed with localized prostate cancer can postpone definitive treatment
without raising their risk of metastasis or death from disease. Active surveillance (AS) is a …

The adverse effects of overdiagnosis and overtreatment observed in men with clinically
insignificant prostate cancers after the introduction of prostate-specific antigen-based …

Context The role of multiparametric magnetic resonance imaging (mp-MRI) during active
surveillance (AS) of prostate cancer needs evaluation. It remains unclear whether mp-MRI …